Management of Very Early-onset Fetal Growth Restriction: Results from 92 Consecutive Cases

Friederike Hoellen1, Annika Beckmann2, Constanze Banz-Jansen2

  • 1Department of Obstetrics and Gynaecology, University Hospital Schleswig-Holstein, Lübeck, Germany friederike.hoellen@uksh.de.

In Vivo (Athens, Greece)
|February 26, 2016
PubMed

Insights

Early-onset intrauterine growth restriction (IUGR) management impacts infant outcomes. A "wait and see" approach may improve survival, but more research is needed for tailored care.

Area of Science:

  • Perinatal Medicine
  • Neonatology
  • Obstetrics

Background:

  • Intrauterine growth restriction (IUGR) presents significant challenges in early-onset cases.
  • Management strategies for early-onset IUGR and preterm delivery require careful consideration.

Purpose of the Study:

  • To evaluate the management of early-onset intrauterine growth restriction (IUGR).
  • To define fetal and neonatal outcomes based on obstetric management settings.

Main Methods:

  • Retrospective review of 92 pregnancies with IUGR and preterm delivery (<30 weeks gestation) between 2000-2011.
  • Analysis of factors influencing fetal outcome, including gestational age at delivery and antenatal corticosteroid use.

Main Results:

  • Sixteen of 92 infants (17.4%) died within one year postpartum.
  • Severe early-onset IUGR contributed to iatrogenic preterm delivery and mortality in eight cases.
  • Gestational age at delivery and antenatal corticosteroid exposure were critical determinants of fetal outcome.

Conclusions:

  • A "wait and see" management approach, alongside respiratory distress syndrome prophylaxis, may be beneficial for prolonging pregnancy in select early-onset IUGR cases.
  • Randomized prospective trials are essential to establish evidence-based guidelines for individualized management of early-onset preterm infants with IUGR.
Abstract